Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine

Affiliations

• ¹ From the Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain (F.F.-A., R.S.-R., A.M.C.); CIBERCV, ISCIII, Madrid, Spain (F.F.-A., R.S.-R., A.M.C., L.B., V.F.); Cardiovascular Research Center (ICCC), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain (L.B.); Institute of Molecular Cardiology, Diabetes and Obesity Center, University of Louisville School of Medicine, KY (R.B.); LabEx TRANSPLANTEX, Paris, France (D.C.); HLA and Médecine Jean Dausset Laboratory Network, Hôpital Saint-Louis AP-HP, Université Paris Diderot, France (D.C.); Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (V.F.); Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (V.F.); Department of Cardiovascular Sciences, KU Leuven, Belgium (S.J.); Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Denmark (J.K.); National Research Laboratory for Stem Cell Niche, Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea (H.-S.K.); Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Korea (H.-S.K.); Department of Cardiology, Royal Brompton and Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, England (T.F.L); University College of London, England (J.F.M.); Department of Cardiovascular Surgery Hôpital Européen Georges Pompidou, Paris, France (P.M.); Université Paris Descartes, Sorbonne Paris Cité, France (P.M.); Serviço de Cardiologia, Hospital Universitário de Santa Maria, CAML, Centro Cardiovascular da Universidade de Lisboa, Universidade de Lisboa, Portugal (F.J.P.); School of Medicine, University of Kansas, Lawrence (R.D.S.); Center for Clinical Trials, Cardiovascular Research Foundation, New York, NY (G.W.S.); Center for Clinical Trials, NewYork-Presbyterian Hospital, Columbia University Medical Center (G.W.S.); Center for Regenerative Medicine (A.T.), Department of Cardiovascular Diseases (A.T.), and Department of Molecular Pharmacology and Experimental Therapeutics (A.T.), Mayo Clinic, Rochester, NY; Department of Regenerative Medicine Research, Texas Heart Institute, Houston (J.T.W.); and Division of Cardiovascular Medicine, Department of Medicine, Stanford Cardiovascular Institute (J.C.W.) and Department of Radiology (J.C.W.), Stanford University School of Medicine, CA. [email protected].
• ² From the Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain (F.F.-A., R.S.-R., A.M.C.); CIBERCV, ISCIII, Madrid, Spain (F.F.-A., R.S.-R., A.M.C., L.B., V.F.); Cardiovascular Research Center (ICCC), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain (L.B.); Institute of Molecular Cardiology, Diabetes and Obesity Center, University of Louisville School of Medicine, KY (R.B.); LabEx TRANSPLANTEX, Paris, France (D.C.); HLA and Médecine Jean Dausset Laboratory Network, Hôpital Saint-Louis AP-HP, Université Paris Diderot, France (D.C.); Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (V.F.); Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (V.F.); Department of Cardiovascular Sciences, KU Leuven, Belgium (S.J.); Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Denmark (J.K.); National Research Laboratory for Stem Cell Niche, Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea (H.-S.K.); Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Korea (H.-S.K.); Department of Cardiology, Royal Brompton and Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, England (T.F.L); University College of London, England (J.F.M.); Department of Cardiovascular Surgery Hôpital Européen Georges Pompidou, Paris, France (P.M.); Université Paris Descartes, Sorbonne Paris Cité, France (P.M.); Serviço de Cardiologia, Hospital Universitário de Santa Maria, CAML, Centro Cardiovascular da Universidade de Lisboa, Universidade de Lisboa, Portugal (F.J.P.); School of Medicine, University of Kansas, Lawrence (R.D.S.); Center for Clinical Trials, Cardiovascular Research Foundation, New York, NY (G.W.S.); Center for Clinical Trials, NewYork-Presbyterian Hospital, Columbia University Medical Center (G.W.S.); Center for Regenerative Medicine (A.T.), Department of Cardiovascular Diseases (A.T.), and Department of Molecular Pharmacology and Experimental Therapeutics (A.T.), Mayo Clinic, Rochester, NY; Department of Regenerative Medicine Research, Texas Heart Institute, Houston (J.T.W.); and Division of Cardiovascular Medicine, Department of Medicine, Stanford Cardiovascular Institute (J.C.W.) and Department of Radiology (J.C.W.), Stanford University School of Medicine, CA.